JSC Retinoids Launches Unique Pharmaceutical Birch Tar Production in Balashikha
JSC Retinoids has organized the production of pharmaceutical-grade purified...
Production of the Russian Smallpox Drug “NIOCH-14” May Start in the Spring of 2026
This is the first chemical drug in Russia intended for the treatment and emergency prevention of smallpox and other orthopoxvirus infections, including mpox.
R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy
The Ministry of Health of the Russian Federation has...
Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Ellara Prepares to Launch Unique Peptide Synthesis Facility
Pharmaceutical company Ellara is completing preparations for the opening...
Strategic Alliance Between Novo Nordisk and OpenAI: AI to Accelerate Drug Development
Danish pharmaceutical giant Novo Nordisk has officially announced a...
CapVest Closes Deal to Acquire Controlling Stake in STADA
International investment firm CapVest Partners has officially announced the...
Eli Lilly to Acquire Centessa Pharmaceuticals for $7.8 Billion to Advance Sleep Disorders Portfolio
Pharmaceutical corporation Eli Lilly has announced a definitive agreement...
EMA Publishes GMDP Inspectors Work Plan for 2026–2028: Focus on AI, Supply Chain Protection, and Global Partnership
The European Medicines Agency (EMA) has presented the three-year...
Top 10 Big Pharma Companies by R&D Spending in 2025 Published
The past year, 2025, proved to be a period...
Russia Simplifies Market Entry for New Veterinary Vaccines: Notification Procedure Established
The Government of the Russian Federation has decided to...
Changes to the EAEU GMP Rules: Updated Requirements for the Manufacture of Sterile Medicinal Products
On April 14, 2026, the EEC Board adopted Resolution...
Ministry of Health Introduces Special Procedure for Individual Gene Therapy
The Ministry of Health of the Russian Federation has...
Russia Approves First National Standard for 3D Bioprinting of Tissues and Organs
Russia has officially adopted the first national standard regulating...
Published Amendments to the EAEU Veterinary Drugs Circulation Rules: The Transition Period has been Extended until 2030
On March 25, the text of EEC Council Decision...
Strategic Alliance Between Novo Nordisk and OpenAI: AI to Accelerate Drug Development
Danish pharmaceutical giant Novo Nordisk has officially announced a...
AI and Billion-Dollar Investments: Eli Lilly Signs an Agreement with Insilico Medicine Worth Up to $2.75 Billion
American pharmaceutical giant Eli Lilly continues to actively invest in artificial intelligence technologies and biotechnological developments.
Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma
On February 25, 2026, pharmaceutical giant Eli Lilly officially...
An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game
The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.
SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule
Researchers at South Ural State University (SUSU) have discovered...
JSC Retinoids Launches Unique Pharmaceutical Birch Tar Production in Balashikha
JSC Retinoids has organized the production of pharmaceutical-grade purified...
Production of the Russian Smallpox Drug “NIOCH-14” May Start in the Spring of 2026
This is the first chemical drug in Russia intended for the treatment and emergency prevention of smallpox and other orthopoxvirus infections, including mpox.
R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy
The Ministry of Health of the Russian Federation has...
Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Ellara Prepares to Launch Unique Peptide Synthesis Facility
Pharmaceutical company Ellara is completing preparations for the opening...
Strategic Alliance Between Novo Nordisk and OpenAI: AI to Accelerate Drug Development
Danish pharmaceutical giant Novo Nordisk has officially announced a...
CapVest Closes Deal to Acquire Controlling Stake in STADA
International investment firm CapVest Partners has officially announced the...
Eli Lilly to Acquire Centessa Pharmaceuticals for $7.8 Billion to Advance Sleep Disorders Portfolio
Pharmaceutical corporation Eli Lilly has announced a definitive agreement...
EMA Publishes GMDP Inspectors Work Plan for 2026–2028: Focus on AI, Supply Chain Protection, and Global Partnership
The European Medicines Agency (EMA) has presented the three-year...
Top 10 Big Pharma Companies by R&D Spending in 2025 Published
The past year, 2025, proved to be a period...
Russia Simplifies Market Entry for New Veterinary Vaccines: Notification Procedure Established
The Government of the Russian Federation has decided to...
Changes to the EAEU GMP Rules: Updated Requirements for the Manufacture of Sterile Medicinal Products
On April 14, 2026, the EEC Board adopted Resolution...
Ministry of Health Introduces Special Procedure for Individual Gene Therapy
The Ministry of Health of the Russian Federation has...
Russia Approves First National Standard for 3D Bioprinting of Tissues and Organs
Russia has officially adopted the first national standard regulating...
Published Amendments to the EAEU Veterinary Drugs Circulation Rules: The Transition Period has been Extended until 2030
On March 25, the text of EEC Council Decision...
Strategic Alliance Between Novo Nordisk and OpenAI: AI to Accelerate Drug Development
Danish pharmaceutical giant Novo Nordisk has officially announced a...
AI and Billion-Dollar Investments: Eli Lilly Signs an Agreement with Insilico Medicine Worth Up to $2.75 Billion
American pharmaceutical giant Eli Lilly continues to actively invest in artificial intelligence technologies and biotechnological developments.
Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma
On February 25, 2026, pharmaceutical giant Eli Lilly officially...
An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game
The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.
SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule
Researchers at South Ural State University (SUSU) have discovered...
PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
Russia Simplifies Market Entry for New Veterinary Vaccines: Notification Procedure Established
The Government of the Russian Federation has decided to...
Kazakh Company Navipharm to Invest 2 Billion Rubles in New Pharma Plant in Dubna SEZ
In the Moscow Region, on the territory of the...
DOM.RF Selects Architectural Design for the New Biomedical and Pharmaceutical Technology Center
The results of the All-Russian competition for the architectural...
Tomsk ECTC to Supply Russian Pharma with Critical Vaccine Raw Material
The Engineering Chemical Technology Center (ECTC) has officially received...
